Establishment and partial characterization of an epirubicin-resistant gastric cancer cell line with upregulated ABCB1

Asian Pac J Cancer Prev. 2014;15(16):6849-53. doi: 10.7314/apjcp.2014.15.16.6849.

Abstract

Multidrug resistance (MDR) is a major impediment to successful chemotherapy of gastric cancer. Our aim was to establish an epirubicin-resistant cell subline (AGS/EPI) and to elucidate the mechanisms involved in acquired EPI resistance. The AGS/EPI cell subline developed by exposing parental AGS cells to stepwise increasing concentrations of EPI demonstrated 2.52-fold resistance relative to the AGS cell line, and mRNA expression of the ATP-dependent drug-efflux pump P-glycoprotein (Pgp), more recently known as ABCB1 protein, was similarly upregulated. An AGS/EPI cell subline could thus be effectively established, and MDR mechanism of these cells was shown to be related to the overexpression of mRNA of the ABCB1 gene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B / biosynthesis
  • ATP Binding Cassette Transporter, Subfamily B / genetics
  • Antibiotics, Antineoplastic / pharmacology*
  • Apoptosis / genetics
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Drug Resistance, Multiple / genetics
  • Drug Resistance, Neoplasm / genetics*
  • Epirubicin / pharmacology*
  • Humans
  • RNA, Messenger / biosynthesis
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / genetics

Substances

  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • Antibiotics, Antineoplastic
  • RNA, Messenger
  • Epirubicin